Logo image of 1NOVN.MI

NOVARTIS AG-REG (1NOVN.MI) Stock Overview

Europe - BIT:1NOVN - CH0012005267 - Common Stock

113 EUR
+13 (+13%)
Last: 10/3/2025, 7:00:00 PM

1NOVN.MI Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap218.75B
Shares1.94B
Float1.79B
Yearly Dividend3.24
Dividend Yield3.76%
EPS(TTM)7.45
PE15.17
Fwd PE14.64
Earnings (Next)10-28 2025-10-28/bmo
IPO05-07 2001-05-07
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


1NOVN.MI short term performance overview.The bars show the price performance of 1NOVN.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months

1NOVN.MI long term performance overview.The bars show the price performance of 1NOVN.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1NOVN.MI is 113 EUR.

NOVARTIS AG-REG / 1NOVN Daily stock chart

1NOVN.MI Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY.DE ELI LILLY & CO 52.3 681.17B
1LLY.MI ELI LILLY & CO 50.82 661.86B
ZEG.DE ASTRAZENECA PLC 19.24 449.11B
JNJ.DE JOHNSON & JOHNSON 18.88 387.36B
1JNJ.MI JOHNSON & JOHNSON 18.07 370.69B
RHO.DE ROCHE HOLDING AG-BR 15.31 260.74B
NOV.DE NOVO NORDISK A/S-B 15.16 224.97B
NOT.DE NOVARTIS AG-REG 15.18 218.87B
1SAN.MI SANOFI 11.5 211.59B
SNW.DE SANOFI 11.49 211.34B
SAN.PA SANOFI 11.42 210.07B
6MK.DE MERCK & CO. INC. 11.68 191.33B

About 1NOVN.MI

Company Profile

1NOVN logo image Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt and currently employs 75,883 full-time employees. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Company Info

NOVARTIS AG-REG

Lichtstrasse 35

Basel BASEL-STADT CH

Employees: 75883

1NOVN Company Website

1NOVN Investor Relations

Phone: 41613241111

NOVARTIS AG-REG / 1NOVN.MI FAQ

What is the stock price of NOVARTIS AG-REG today?

The current stock price of 1NOVN.MI is 113 EUR. The price increased by 13% in the last trading session.


What is the ticker symbol for NOVARTIS AG-REG stock?

The exchange symbol of NOVARTIS AG-REG is 1NOVN and it is listed on the Euronext Milan exchange.


On which exchange is 1NOVN.MI stock listed?

1NOVN.MI stock is listed on the Euronext Milan exchange.


What is NOVARTIS AG-REG worth?

NOVARTIS AG-REG (1NOVN.MI) has a market capitalization of 218.75B EUR. This makes 1NOVN.MI a Mega Cap stock.


How many employees does NOVARTIS AG-REG have?

NOVARTIS AG-REG (1NOVN.MI) currently has 75883 employees.


Is NOVARTIS AG-REG (1NOVN.MI) expected to grow?

The Revenue of NOVARTIS AG-REG (1NOVN.MI) is expected to grow by 7.74% in the next year. Check the estimates tab for more information on the 1NOVN.MI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NOVARTIS AG-REG (1NOVN.MI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NOVARTIS AG-REG (1NOVN.MI) stock pay dividends?

NOVARTIS AG-REG (1NOVN.MI) has a dividend yield of 3.76%. The yearly dividend amount is currently 3.24. Check the full fundamental report for a detailed analysis of 1NOVN.MI dividend history, reliability and sustainability.


When does NOVARTIS AG-REG (1NOVN.MI) report earnings?

NOVARTIS AG-REG (1NOVN.MI) will report earnings on 2025-10-28, before the market open.


What is the Price/Earnings (PE) ratio of NOVARTIS AG-REG (1NOVN.MI)?

The PE ratio for NOVARTIS AG-REG (1NOVN.MI) is 15.17. This is based on the reported non-GAAP earnings per share of 7.45 and the current share price of 113 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1NOVN.MI.


1NOVN.MI Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to 1NOVN.MI.


Chartmill TA Rating
Chartmill Setup Rating

1NOVN.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to 1NOVN.MI. 1NOVN.MI gets an excellent profitability rating and is at the same time showing great financial health properties.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1NOVN.MI Financial Highlights

Over the last trailing twelve months 1NOVN.MI reported a non-GAAP Earnings per Share(EPS) of 7.45. The EPS increased by 22.58% compared to the year before.


Industry RankSector Rank
PM (TTM) 24.9%
ROA 13.08%
ROE 32.52%
Debt/Equity 0.57
Chartmill High Growth Momentum
EPS Q2Q%22.84%
Sales Q2Q%9.18%
EPS 1Y (TTM)22.58%
Revenue 1Y (TTM)12.24%

1NOVN.MI Forecast & Estimates

For the next year, analysts expect an EPS growth of 11.31% and a revenue growth 7.74% for 1NOVN.MI


Analysts
Analysts68.75
Price TargetN/A
EPS Next Y11.31%
Revenue Next Year7.74%

1NOVN.MI Ownership

Ownership
Inst Owners34.27%
Ins Owners0.01%
Short Float %N/A
Short RatioN/A